BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20360208)

  • 1. Extensive arterial thrombosis in a patient with factor V Leiden mutation.
    Mandegar MH; Saidi B; Roshanali F
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):127-9. PubMed ID: 20360208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute mesenteric and aortic thrombosis associated with antithrombin deficiency: a rare occurrence.
    Calcaterra D; Martin JT; Ferneini AM; De Natale RW
    Ann Vasc Surg; 2010 Apr; 24(3):415.e5-7. PubMed ID: 19932950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous factor V Leiden mutation and disseminated thrombosis in a patient with nephrotic syndrome.
    Kahveci A; Seyahi N; Seyahi E; Altiparmak MR; Ataman R; Serdengecti K
    J Nephrol; 2007; 20(1):103-6. PubMed ID: 17347983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic arch thrombosis in a neonate with heterozygous carrier status of factor V Leiden mutation.
    Metsvaht T; Hermlin T; Kern H; Kahre T; Starkopf J
    Congenit Heart Dis; 2006 Jan; 1(1-2):40-5. PubMed ID: 18373789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden mutation modulates the bleeding phenotype in warfarin sensitive patients.
    Gaikwad T; Ghosh K; Kulkarni B; Shetty S
    Thromb Res; 2014 May; 133(5):955-6. PubMed ID: 24630642
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal aortic arch thrombosis: analysis of thrombophilic risk factors and prognosis.
    Wieland I; Jack T; Seidemann K; Boehne M; Schmidt F; Happel CM; Koeditz H; Bertram H; Sasse M
    Cardiol Young; 2014 Feb; 24(1):33-9. PubMed ID: 23336428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic thoracic aorta mural thrombus.
    Roche-Nagle G; Wooster D; Oreopoulos G
    Vascular; 2010; 18(1):41-4. PubMed ID: 20122360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation in factor II and factor V gene in patients with peripheral arterial occlusive disease].
    Abukishe A; Brandt M; Hedderich J; Hirt S; Lentz S; Schäfer H; Walluscheck K; Cremer J; Bruhn HD
    Hamostaseologie; 2006 Aug; 26(3):197-200. PubMed ID: 16906235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the factor V Leiden paradox.
    van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    De Paulis S; Rossi E; Zamparelli R; Scapigliati A; Corrado M; De Stefano V
    Thromb Haemost; 2008 Feb; 99(2):441-2. PubMed ID: 18278197
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients.
    de Paula Sabino A; Ribeiro DD; Carvalho Md; Cardoso J; Dusse LM; Fernandes AP
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):271-5. PubMed ID: 16651869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant thrombus in the ascending aorta that caused systemic embolism.
    Sawada T; Shimokawa T
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1048-50. PubMed ID: 21422157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental discovery of an ascending aortic thrombus: should this patient undergo surgical intervention?
    Chatterjee S; Eagle SS; Adler DH; Byrne JG
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):e14-6. PubMed ID: 19691995
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Cooley BC; Chen CY; Schmeling G
    Thromb Res; 2007; 119(6):747-51. PubMed ID: 16793123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial thrombosis and the role of thrombophilia.
    Boekholdt SM; Kramer MH
    Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
    Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
    J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
    Cushman M; Rosendaal FR; Psaty BM; Cook EF; Valliere J; Kuller LH; Tracy RP
    Thromb Haemost; 1998 May; 79(5):912-5. PubMed ID: 9609219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper gastrointestinal bleeding in a young patient with Budd Chiari syndrome due to a mutation of factor V Leiden: a case report.
    Dina I; Iacobescu C; Goldis A
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):213-5. PubMed ID: 23799222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nephrotic syndrome: an unusual case of multiple embolic events.
    Schwartz JC; Wyrzykowski AD; Dente CJ; Nicholas JM
    Vasc Endovascular Surg; 2009; 43(2):207-10. PubMed ID: 18838397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.